Corrigendum: Irisin promotes osteoblast proliferation and differentiation via activating the MAP kinase signaling pathways.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

8 citing papers in PubMed.

1. Sex specific effects of irisin on the skeleton.Bone research · 2026
   Review
2. Irisin: muscle's novel player in endoplasmic reticulum stress and disease.Molecular and cellular biochemistry · 2025
   Review
3. Bone and muscle crosstalk in ageing and disease.Nature reviews. Endocrinology · 2025
   Review
4. Elucidating the mechanism of triphenyl phosphate interference in bone metabolism via network toxicology and molecular docking methodologies.Frontiers in endocrinology · 2025
   Article
5. Irisin promotes intestinal epithelial cell proliferation via Wnt/β-catenin and focal adhesion kinase signaling pathways.Scientific reports · 2024
   Article
6. Irisin as a predictor of bone metabolism in Han Chinese Young Men with pre-diabetic individuals.BMC endocrine disorders · 2022
   Article
7. Roles and Mechanisms of Irisin in Attenuating Pathological Features of Osteoarthritis.Frontiers in cell and developmental biology · 2021
   Article
8. Crosstalk Between Muscle and Bone Via the Muscle-Myokine Irisin.Current osteoporosis reports · 2016
   Review

Corrections and comments

• Erratum for
  Irisin promotes osteoblast proliferation and differentiation via activating the MAP kinase signaling pathways.2016 · Yong Qiao, Xiao [corrected to Qiao, Xiaoyong]; Xian Ma, Ya [corrected to Ma, Yaxian]; Yao Yinrg, Wei [corrected to Yin, Weiyao]; Ming Xu, Wen [corrected to Xu, Wenming]; Zhi Xu, Liang [corrected to Xu, Liangzhi]

Authors and funding

9 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.